Pfizer
This article was originally published in The Tan Sheet
Executive Summary
Receives warning letter from FDA on June 3 regarding "allergy relief" claims for Visine AC eye drops. The agency noted that OTC ophthalmic vasoconstrictor drugs may only be indicated for "relieves redness of the eye due to minor eye irritations" and not for allergies. Pfizer said it plans to "fully cooperate" with the agency